Enterome vs Ray Therapeutics
Enterome vs Ray Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and Ray Therapeutics on 53/100.
Where each one leads
Enterome
- our overall score: 60/100 against 53/100
- domain rating: 46/100 against 29/100
Ray Therapeutics
- funding raised: $243M against $124M
At a glance
| Measure | Enterome | Ray Therapeutics |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. | Pioneering vision restoration therapies for severe retinal degenerations. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 2012 | 2021 |
| Headquarters | Paris, France | Berkeley, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Enterome | Ray Therapeutics |
|---|---|---|
| Employees | 33 | Not published |
| Total funding | $124M | $243M |
| Latest round | Later Stage VC | Series B |
| LinkedIn followers | 16,846 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enterome | Ray Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 53/100 |
| Traction | 55/100 | 40/100 |
| Team | 70/100 | 50/100 |
| Search visibility | 34/100 | 14/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enterome | Ray Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Analytics 4, Segment | Google Analytics 4 |
Enterome vs Ray Therapeutics: common questions
Which is better, Enterome or Ray Therapeutics?
On our 0-100 score Enterome rates higher (60/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Enterome and Ray Therapeutics compare on the numbers?
Enterome leads on our overall score (60/100 against 53/100), domain rating (46/100 against 29/100). Ray Therapeutics leads on funding raised ($243M against $124M).
Read the full Enterome review and pricing or the Ray Therapeutics review and pricing. You can also browse other Enterome alternatives we track.